1 – 10 of 12
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
To pick, choose, or single out.
(
- Contribution to journal › Debate/Note/Editorial
- 2011
-
Mark
Vasomotor menopausal symptoms are associated with increased risk of coronary heart disease.
(
- Contribution to journal › Article
- 2009
-
Mark
Nonhormonal drug use and its relation to androgens in perimenopausal women: a population-based study of Swedish women. The Women's Health in the Lund Area Study.
(
- Contribution to journal › Article
-
Mark
Prevalence of symptoms in relation to androgen concentrations in women using estrogen plus progestogen and women using estrogen alone.
(
- Contribution to journal › Article
-
Mark
Vasomotor symptoms are associated with a lower bone mineral density.
(
- Contribution to journal › Article
- 2007
-
Mark
Low-dose continuous combinations of hormone therapy and biochemical surrogate markers for vascular tone and inflammation: transdermal versus oral application.
(
- Contribution to journal › Article
- 2005
-
Mark
Effects of ospemifene and raloxifene on hormonal status, lipids, genital tract and tolerability in postmenopausal women
(
- Contribution to journal › Article
-
Mark
Prevalence of urinary incontinence in relation to self-reported depression, intake of serotonergic antidepressants, and hormone therapy in middle-aged women: a report from the Women's Health in the Lund Area study.
(
- Contribution to journal › Article
- 2004
-
Mark
Combined hormone therapy in postmenopausal women with features of metabolic syndrome. Results from a population-based study of Swedish women: Women’s Health in the Lund Area study.
(
- Contribution to journal › Article
- 2002
-
Mark
Changes in lipid and lipoprotein profile in postmenopausal women receiving low-dose combinations of 17 beta-estradiol and norethisterone acetate
(
- Contribution to journal › Article